Hospital Overload: Manila’s Justice Jose Abad Santos General Hospital says its ER is at 300% capacity as flooding drives a surge of patients, including suspected and confirmed leptospirosis cases. Big Pharma Deal: Eli Lilly signed an agreement to acquire Merida Biosciences for up to about $2.875B, aiming to expand its precision immunology pipeline. Diabetes + Heart Outcomes: The FDA approved Mounjaro (tirzepatide) to reduce major cardiovascular events in adults with type 2 diabetes. Cancer Trial Update: BioNTech terminated its Phase 2 autogene cevumeran (Cevumeran) colorectal cancer study after a DSMB flagged an overall survival imbalance. Medtech Safety Recall: Boston Scientific is stopping distribution of certain Imager II angiographic catheters after a manufacturing issue could raise the risk of tip detachment. Access & Equity: A KFF survey finds LGBTQ+ adults are far more likely to miss or forgo care due to cost, with many reporting worsening health. Public Health Pressure: Denmark’s HeartRunner trial found community first responders didn’t improve 30-day out-of-hospital cardiac arrest survival. Workforce & Capacity: Saskatchewan is expanding Regina General Hospital’s NICU by three beds to support premature and medically fragile newborns. Healthcare in the Real World: Boston Scientific’s catheter issue and Manila’s ER strain both underline how quickly system stress can turn into patient risk.